Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis

Journal of Neuro-Oncology 100 巻 3 号 449-457 頁 2010-12 発行
アクセス数 : 1032
ダウンロード数 : 216

今月のアクセス数 : 6
今月のダウンロード数 : 3
ファイル情報(添付)
JNeuroOncol_100_449.pdf 1.24 MB 種類 : 全文
タイトル ( eng )
Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis
作成者
Watanabe Yosuke
Kajiwara Yoshinori
Nishimoto Takeshi
Bartholomeusz Chandra
Ueno Naoto T
収録物名
Journal of Neuro-Oncology
100
3
開始ページ 449
終了ページ 457
抄録
Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) is a multifunctional protein that was first identified in brain astrocytes and that has subsequently been shown to be expressed in different tissues. Despite its many important roles, the clinical significance of PEA-15 expression levels in astrocytic tumors has yet to be properly defined. We studied the PEA-15 expression pattern of 65 patients [diagnosed according to World Health Organization (WHO) criteria] with diffuse astrocytoma (WHO grade II), anaplastic astrocytoma (grade III), and glioblastoma (grade IV). PEA-15 expression levels were immunohistochemically measured and categorized as no, low, or high expression. All tumors expressed PEA-15 in our study. Twenty-three (35.4%) and 42 (64.6%) tumors expressed low and high PEA-15 levels, respectively. In grade II astrocytoma (diffuse astrocytoma) and grade III astrocytoma (anaplastic astrocytoma), 100% and 88.9% of patients expressed high PEA-15 levels, respectively, while a smaller number (50%) of patients with grade IV astrocytoma (glioblastoma) expressed high PEA-15 levels. PEA-15 expression level was inversely associated with WHO grade (P = 0.0006). Next, we evaluated prognosis and PEA-15 expression levels in 43 patients with high-grade astrocytomas based on the following parameters: age, gender, WHO grade, surgical resection extent, MIB-1 labeling index (LI), and PEA-15 expression level. Multivariable analyses revealed that high PEA-15 expression level displayed a significant correlation with longer overall survival (OS) in high-grade astrocytomas (P = 0.0024). Patients with total resection survived significantly longer (P = 0.0044) than those with lower resection extent, while patients with MIB-1 labeling index a parts per thousand currency sign25% indicated significant (P = 0.0434) correlation with OS as well. In conclusion, PEA-15 expression level was inversely associated with WHO grade and may serve as an important prognostic factor for high-grade astrocytomas.
著者キーワード
Phosphoprotein enriched in astrocytes 15 kDa
Astrocytic tumor
Malignancy grade
Prognosis
Immunohistochemistry
NDC分類
医学 [ 490 ]
言語
英語
資源タイプ 学術雑誌論文
出版者
Springer
発行日 2010-12
権利情報
Copyright (c) 2010 Springer
出版タイプ Author’s Original(十分な品質であるとして、著者から正式な査読に提出される版)
アクセス権 オープンアクセス
収録物識別子
The original publication is available at www.springerlink.com
[ISSN] 0167-594X
[DOI] 10.1007/s11060-010-0201-1
[NCID] AA10633712
[DOI] http://dx.doi.org/10.1007/s11060-010-0201-1